Retained Earnings (Accumulated Deficit) in USD of Scinai Immunotherapeutics Ltd. from Q4 2021 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Scinai Immunotherapeutics Ltd. quarterly Retained Earnings (Accumulated Deficit) history and change rate from Q4 2021 to Q2 2025.
  • Scinai Immunotherapeutics Ltd. Retained Earnings (Accumulated Deficit) for the quarter ending 30 Jun 2025 was $121,673,000, a 4.1% increase year-over-year.
Source SEC data
View on sec.gov
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Change (%)

Scinai Immunotherapeutics Ltd. Quarterly Retained Earnings (Accumulated Deficit) (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $121,673,000 +$5,143,000 +4.1% 30 Jun 2025 6-K 02 Sep 2025 2025 Q2
Q4 2024 $117,539,000 +$4,796,000 +3.9% 31 Dec 2024 6-K 02 Sep 2025 2025 Q2
Q2 2024 $126,816,000 -$3,704,000 -3% 30 Jun 2024 6-K 09 Sep 2024 2024 Q2
Q4 2023 $122,335,000 -$6,500,000 -5.6% 31 Dec 2023 20-F 07 May 2025 2024 FY
Q2 2023 $123,112,000 30 Jun 2023 6-K/A 18 Aug 2023 2023 Q2
Q1 2023 $119,350,000 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $115,835,000 -$5,796,000 -5.3% 31 Dec 2022 20-F 15 May 2024 2023 FY
Q4 2021 $110,039,000 31 Dec 2021 10-K 17 Apr 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.